The global burden of diabetic foot disease

被引:1783
作者
Boulton, AJM [1 ]
Vileikyte, L
Ragnarson-Tennvall, G
Apelqvist, J
机构
[1] Univ Manchester, Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
[2] Univ Miami, Div Endocrinol Diabet & Metab, Miami, FL 33152 USA
[3] Swedish Inst Hlth Econ, Lund, Sweden
[4] Lund Univ, Malmo Univ Hosp, Dept Endocrinol, S-22100 Lund, Sweden
关键词
D O I
10.1016/S0140-6736(05)67698-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic foot problems are common throughout the world, resulting in major economic consequences for the patients, their families, and society. Foot ulcers are more likely to be of neuropathic origin, and therefore eminently preventable, in developing countries, which will experience the greatest rise in the prevalence of type 2 diabetes in the next 20 years. People at greatest risk of ulceration can easily be identified by careful clinical examination of the feet: education and frequent follow-up is indicated for these patients. When assessing the economic effects of diabetic foot disease, it is important to remember that rates of recurrence of foot ulcers are very high, being greater than 50% after 3 years. Costing should therefore include not only the immediate ulcer episode, but also social services, home care, and subsequent ulcer episodes. A broader view of total resource use should include some estimate of quality of life and the final outcome. An integrated care approach with regular screening and education of patients at risk requires low expenditure and has the potential to reduce the cost of health care.
引用
收藏
页码:1719 / 1724
页数:6
相关论文
共 78 条
  • [61] Diabetes care in an Australian population - Frequency of screening examinations for eye and foot complications of diabetes
    Tapp, RJ
    Zimmet, PZ
    Harper, CA
    De Courten, MP
    Balkau, B
    McCarty, DJ
    Taylor, HR
    Welborn, TA
    Shaw, JE
    [J]. DIABETES CARE, 2004, 27 (03) : 688 - 693
  • [62] Foot complications in Type 2 diabetes: an Australian population-based study
    Tapp, RJ
    Shaw, JE
    de Courten, MP
    Dunstan, DW
    Welborn, TA
    Zimmet, PZ
    [J]. DIABETIC MEDICINE, 2003, 20 (02) : 105 - 113
  • [63] Tchakonte B, 2005, Bull Soc Pathol Exot, V98, P94
  • [64] Tennvall GR, 2000, J INTERN MED, V248, P397
  • [65] Health-economic consequences of diabetic foot lesions
    Tennvall, GR
    Apelqvist, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 : S132 - S139
  • [66] Costs of deep foot infections in patients with diabetes mellitus
    Tennvall, GR
    Apelqvist, J
    Eneroth, M
    [J]. PHARMACOECONOMICS, 2000, 18 (03) : 225 - 238
  • [67] Unchanged incidence of lower-limb amputations in a German City, 1990-1998
    Trautner, C
    Haastert, B
    Spraul, M
    Giani, G
    Berger, M
    [J]. DIABETES CARE, 2001, 24 (05) : 855 - 859
  • [68] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853
  • [69] Cost and resource utilization for prevention and treatment of foot lesions in a diabetic foot clinic in Belgium
    Van Acker, K
    Oleen-Burkey, M
    De Decker, L
    Vanmaele, R
    Van Schil, P
    Matricali, G
    De Leeuw, I
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 (02) : 87 - 95
  • [70] Reduction in diabetes-related lower-extremity amputations in the Netherlands: 1991-2000
    van Houtum, WH
    Rauwerda, JA
    Ruwaard, D
    Schaper, NC
    Bakker, K
    [J]. DIABETES CARE, 2004, 27 (05) : 1042 - 1046